| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 0450 |
Emergency room services |
254,320 |
227,868 |
$8.67M |
| 99199 |
Unlisted special service, procedure or report |
44,886 |
39,010 |
$7.68M |
| T1999 |
Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks" |
21,687 |
13,205 |
$2.35M |
| 80053 |
Comprehensive metabolic panel |
209,304 |
191,600 |
$2.02M |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
46,710 |
43,384 |
$1.11M |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
27,837 |
26,937 |
$1.01M |
| 0360 |
|
15,303 |
13,603 |
$969K |
| Z7502 |
|
21,120 |
20,725 |
$769K |
| 80306 |
|
37,291 |
35,140 |
$511K |
| J1745 |
Injection, infliximab, excludes biosimilar, 10 mg |
477 |
449 |
$404K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
23,975 |
22,225 |
$403K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
26,957 |
24,618 |
$382K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
13,964 |
13,594 |
$349K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
13,871 |
12,327 |
$336K |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
10,975 |
10,684 |
$314K |
| 71046 |
Radiologic examination, chest; 2 views |
68,947 |
61,505 |
$314K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
12,135 |
11,319 |
$293K |
| J3490 |
Unclassified drugs |
69,824 |
45,304 |
$281K |
| 81001 |
|
147,168 |
136,535 |
$280K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
37,792 |
34,681 |
$275K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
16,971 |
15,985 |
$267K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
10,761 |
10,479 |
$244K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
36,626 |
34,645 |
$233K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
222,303 |
201,914 |
$218K |
| 71045 |
Radiologic examination, chest; single view |
81,970 |
65,488 |
$194K |
| Q5103 |
Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg |
898 |
774 |
$189K |
| 70450 |
Computed tomography, head or brain; without contrast material |
24,298 |
21,701 |
$187K |
| 99070 |
|
58,440 |
34,923 |
$174K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
20,918 |
18,320 |
$172K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
68,153 |
62,357 |
$165K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
54,077 |
51,398 |
$157K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
11,147 |
10,799 |
$157K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
7,781 |
7,264 |
$150K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
7,978 |
7,785 |
$146K |
| 0250 |
|
19,157 |
16,021 |
$139K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
16,635 |
14,624 |
$137K |
| 0270 |
|
103,943 |
59,793 |
$124K |
| 86850 |
|
9,417 |
9,001 |
$120K |
| 73130 |
|
11,020 |
9,943 |
$120K |
| 73610 |
|
10,534 |
9,398 |
$119K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
28,085 |
27,404 |
$118K |
| 73562 |
|
13,198 |
11,769 |
$113K |
| 73630 |
|
15,286 |
13,831 |
$112K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
14,771 |
14,141 |
$110K |
| 81025 |
|
44,128 |
42,178 |
$109K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
9,364 |
9,297 |
$106K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
7,530 |
6,686 |
$100K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
16,336 |
15,902 |
$97K |
| 86900 |
|
13,945 |
13,100 |
$96K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
16,682 |
15,533 |
$92K |
| 73030 |
|
11,605 |
10,378 |
$92K |
| 86901 |
|
13,954 |
13,108 |
$91K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
1,272 |
1,160 |
$88K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
3,608 |
3,545 |
$83K |
| 0710 |
|
8,186 |
7,931 |
$81K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
15,689 |
13,848 |
$79K |
| 84443 |
Thyroid stimulating hormone (TSH) |
52,077 |
51,230 |
$73K |
| 84702 |
|
12,657 |
10,360 |
$72K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
13,155 |
12,416 |
$71K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
3,919 |
3,669 |
$70K |
| 80143 |
|
3,287 |
2,970 |
$69K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
18,424 |
16,517 |
$68K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
31,471 |
31,170 |
$67K |
| 74018 |
|
10,944 |
9,660 |
$64K |
| 82962 |
|
9,051 |
6,929 |
$62K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
12,970 |
11,221 |
$61K |
| 80061 |
Lipid panel |
48,533 |
48,122 |
$59K |
| 90715 |
|
4,513 |
4,492 |
$58K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
27,917 |
24,539 |
$57K |
| 87081 |
|
8,015 |
7,894 |
$57K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
6,046 |
5,761 |
$55K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
34,722 |
11,312 |
$55K |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
1,000 |
970 |
$54K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
3,168 |
2,972 |
$54K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
27,184 |
24,640 |
$53K |
| J2704 |
Injection, propofol, 10 mg |
11,809 |
11,480 |
$53K |
| 73110 |
|
5,316 |
4,775 |
$53K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
10,924 |
10,093 |
$52K |
| 87186 |
|
14,507 |
13,960 |
$51K |
| 83880 |
|
17,743 |
16,544 |
$50K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
2,745 |
2,436 |
$49K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
16,434 |
14,315 |
$48K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
45,973 |
45,428 |
$46K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
16,154 |
15,726 |
$44K |
| 0259 |
|
3,570 |
2,564 |
$42K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
19,512 |
17,096 |
$40K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
6,534 |
6,148 |
$40K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
3,134 |
3,046 |
$40K |
| 72100 |
|
7,497 |
6,660 |
$39K |
| 70486 |
|
2,671 |
2,335 |
$39K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
13,537 |
12,715 |
$39K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
21,890 |
19,405 |
$38K |
| 73080 |
|
3,076 |
2,727 |
$37K |
| 76770 |
|
8,157 |
7,259 |
$37K |
| J2060 |
Injection, lorazepam, 2 mg |
3,903 |
3,426 |
$36K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
2,807 |
2,532 |
$35K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
6,188 |
5,283 |
$35K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
24,181 |
20,665 |
$35K |
| 73221 |
|
1,353 |
1,213 |
$33K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
16,139 |
15,970 |
$33K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
1,543 |
1,366 |
$33K |
| 72040 |
|
3,434 |
3,040 |
$32K |
| 76801 |
|
12,590 |
9,756 |
$32K |
| 76830 |
Ultrasound, transvaginal |
14,661 |
12,800 |
$32K |
| 71250 |
|
3,272 |
2,934 |
$31K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
593 |
588 |
$30K |
| 76536 |
|
6,648 |
5,857 |
$29K |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
2,026 |
1,944 |
$27K |
| J1815 |
Injection, insulin, per 5 units |
3,352 |
2,323 |
$26K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
11,504 |
10,024 |
$26K |
| 77066 |
Tomosynthesis, mammo |
5,649 |
4,878 |
$26K |
| 76642 |
|
10,213 |
8,873 |
$26K |
| 71101 |
|
1,564 |
1,365 |
$26K |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
1,029 |
993 |
$25K |
| 84484 |
|
41,081 |
35,743 |
$25K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
1,135 |
1,119 |
$24K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
9,795 |
9,347 |
$24K |
| 73590 |
|
2,570 |
2,260 |
$24K |
| 73090 |
|
2,284 |
2,012 |
$23K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
3,838 |
3,353 |
$23K |
| 86780 |
|
14,174 |
13,639 |
$23K |
| 87077 |
|
16,056 |
15,387 |
$20K |
| 74178 |
|
753 |
659 |
$20K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
25,407 |
9,210 |
$20K |
| 73502 |
|
3,318 |
2,965 |
$20K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
5,236 |
1,888 |
$20K |
| J1630 |
Injection, haloperidol, up to 5 mg |
1,867 |
1,591 |
$20K |
| 83690 |
|
54,275 |
50,877 |
$20K |
| 0324 |
|
1,381 |
1,325 |
$20K |
| 0762 |
|
767 |
284 |
$19K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
881 |
843 |
$19K |
| 87070 |
|
3,213 |
3,138 |
$18K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
23,249 |
22,628 |
$18K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
4,537 |
3,117 |
$17K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
2,870 |
2,471 |
$17K |
| 72131 |
|
1,844 |
1,601 |
$16K |
| 80074 |
|
3,615 |
3,526 |
$16K |
| 12001 |
|
602 |
602 |
$16K |
| 74019 |
|
3,601 |
3,186 |
$16K |
| 0121 |
|
437 |
399 |
$15K |
| 73620 |
|
1,585 |
1,378 |
$15K |
| S0077 |
Injection, clindamycin phosphate, 300 mg |
1,141 |
927 |
$15K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
2,379 |
2,140 |
$15K |
| 95811 |
|
907 |
898 |
$15K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,005 |
965 |
$15K |
| 76870 |
|
2,682 |
2,250 |
$14K |
| 86920 |
|
875 |
771 |
$14K |
| 59025 |
Fetal non-stress test |
11,085 |
6,302 |
$14K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
11,594 |
4,442 |
$14K |
| 73120 |
|
966 |
861 |
$14K |
| 77065 |
Tomosynthesis, mammo |
2,972 |
2,556 |
$14K |
| J1940 |
Injection, furosemide, up to 20 mg |
1,042 |
829 |
$13K |
| 73560 |
|
1,924 |
1,684 |
$13K |
| 72141 |
|
430 |
404 |
$13K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
18,624 |
17,960 |
$13K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
5,024 |
3,807 |
$13K |
| 85730 |
|
11,298 |
10,725 |
$12K |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
1,685 |
1,653 |
$12K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
1,179 |
1,157 |
$12K |
| 93971 |
|
4,484 |
3,891 |
$11K |
| 84439 |
|
17,337 |
17,060 |
$11K |
| 85610 |
|
24,178 |
22,466 |
$11K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
560 |
559 |
$11K |
| 72070 |
|
2,004 |
1,835 |
$11K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
322 |
319 |
$11K |
| 0403 |
|
207 |
207 |
$11K |
| Z7610 |
|
8,765 |
5,272 |
$11K |
| 73564 |
|
3,064 |
2,843 |
$10K |
| J1720 |
Injection, hydrocortisone sodium succinate, up to 100 mg |
1,104 |
986 |
$10K |
| J7050 |
Infusion, normal saline solution, 250 cc |
2,735 |
2,356 |
$10K |
| 86803 |
|
7,264 |
7,206 |
$10K |
| 82607 |
|
12,615 |
12,479 |
$10K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
2,835 |
2,573 |
$10K |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
1,820 |
1,742 |
$10K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
107 |
107 |
$10K |
| 82274 |
|
3,393 |
3,363 |
$9K |
| 0760 |
|
2,453 |
1,760 |
$9K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
1,814 |
1,617 |
$8K |
| 83013 |
|
1,865 |
1,860 |
$8K |
| 0300 |
|
1,418 |
1,241 |
$8K |
| 82043 |
|
14,416 |
14,221 |
$8K |
| 84153 |
|
3,700 |
3,649 |
$8K |
| 87807 |
|
1,178 |
1,147 |
$8K |
| 84703 |
|
10,254 |
9,992 |
$8K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
10,532 |
9,428 |
$8K |
| 86003 |
|
734 |
454 |
$8K |
| 73600 |
|
545 |
482 |
$8K |
| 36415 |
Collection of venous blood by venipuncture |
7,561 |
6,676 |
$7K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
7,592 |
2,608 |
$7K |
| 12002 |
|
375 |
375 |
$7K |
| 87040 |
|
14,212 |
7,906 |
$7K |
| C1776 |
Joint device (implantable) |
13 |
13 |
$7K |
| 86481 |
|
1,804 |
1,785 |
$7K |
| 83655 |
|
8,959 |
8,813 |
$7K |
| 82805 |
|
2,224 |
2,072 |
$7K |
| 72110 |
|
4,308 |
3,968 |
$7K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
4,376 |
3,869 |
$6K |
| 84145 |
|
955 |
930 |
$6K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
467 |
446 |
$6K |
| 84481 |
|
6,334 |
6,248 |
$6K |
| 47562 |
|
58 |
54 |
$6K |
| 96415 |
|
1,747 |
1,558 |
$6K |
| 73060 |
|
465 |
407 |
$6K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
758 |
639 |
$6K |
| 97750 |
|
3,200 |
1,881 |
$5K |
| 76857 |
|
3,590 |
3,034 |
$5K |
| 72170 |
|
810 |
736 |
$5K |
| 70360 |
|
307 |
267 |
$5K |
| 93970 |
|
1,080 |
932 |
$5K |
| 87340 |
|
6,003 |
5,925 |
$5K |
| 80076 |
|
3,218 |
3,157 |
$5K |
| 86762 |
|
4,628 |
4,183 |
$5K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
669 |
611 |
$5K |
| 86635 |
|
3,509 |
1,963 |
$5K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,344 |
2,275 |
$5K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
136 |
131 |
$5K |
| 70491 |
|
469 |
407 |
$5K |
| 82105 |
|
732 |
724 |
$5K |
| 84403 |
|
2,236 |
2,130 |
$4K |
| 86694 |
|
1,758 |
1,415 |
$4K |
| 84550 |
|
5,643 |
5,464 |
$4K |
| 83001 |
|
2,373 |
2,353 |
$4K |
| 74022 |
|
569 |
493 |
$4K |
| 86038 |
|
3,949 |
3,891 |
$4K |
| 77080 |
|
2,278 |
1,959 |
$4K |
| 84146 |
|
2,012 |
1,992 |
$4K |
| 12011 |
|
196 |
195 |
$4K |
| 29125 |
|
327 |
315 |
$4K |
| 83605 |
|
12,532 |
10,458 |
$4K |
| 83735 |
|
17,499 |
16,329 |
$3K |
| 80305 |
|
448 |
443 |
$3K |
| 86480 |
|
591 |
581 |
$3K |
| 73552 |
|
428 |
378 |
$3K |
| 0401 |
|
35 |
35 |
$3K |
| 85027 |
|
5,325 |
5,261 |
$3K |
| 0160 |
|
819 |
326 |
$3K |
| 83970 |
|
1,677 |
1,645 |
$3K |
| 97010 |
|
7,390 |
2,971 |
$3K |
| 82728 |
|
4,440 |
4,354 |
$3K |
| 0320 |
|
168 |
160 |
$3K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
19,786 |
19,185 |
$3K |
| 87045 |
|
654 |
640 |
$3K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
1,489 |
1,214 |
$3K |
| 81220 |
CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants |
157 |
156 |
$3K |
| 86141 |
|
3,281 |
3,212 |
$3K |
| 82746 |
|
3,950 |
3,902 |
$3K |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
952 |
927 |
$3K |
| 83002 |
|
1,742 |
1,722 |
$3K |
| 97014 |
|
6,547 |
2,580 |
$3K |
| J3370 |
Injection, vancomycin hcl, 500 mg |
389 |
283 |
$3K |
| 87210 |
|
2,296 |
2,231 |
$3K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
1,218 |
1,087 |
$3K |
| 76981 |
|
211 |
205 |
$2K |
| 97163 |
|
1,585 |
1,577 |
$2K |
| 10060 |
|
167 |
162 |
$2K |
| 86787 |
|
2,266 |
1,874 |
$2K |
| 84436 |
|
3,394 |
3,372 |
$2K |
| 73100 |
|
283 |
263 |
$2K |
| 97016 |
|
3,640 |
1,254 |
$2K |
| 72050 |
|
1,251 |
1,181 |
$2K |
| 80179 |
|
3,160 |
2,895 |
$2K |
| 86140 |
|
5,418 |
5,288 |
$2K |
| J3260 |
Injection, tobramycin sulfate, up to 80 mg |
502 |
494 |
$2K |
| 73700 |
|
213 |
181 |
$2K |
| 86235 |
|
971 |
736 |
$2K |
| 49083 |
|
102 |
64 |
$2K |
| 86696 |
|
1,086 |
1,077 |
$2K |
| 70496 |
|
448 |
405 |
$2K |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
565 |
522 |
$2K |
| 84466 |
|
2,924 |
2,867 |
$2K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
68 |
67 |
$2K |
| 94060 |
|
373 |
370 |
$2K |
| 82248 |
|
2,236 |
2,064 |
$2K |
| 83516 |
|
2,407 |
1,665 |
$2K |
| 82553 |
|
2,119 |
1,984 |
$2K |
| 86317 |
|
1,383 |
1,357 |
$2K |
| 74181 |
|
47 |
41 |
$2K |
| J0558 |
Injection, penicillin g benzathine and penicillin g procaine, 100,000 units |
13 |
13 |
$2K |
| 80069 |
|
1,844 |
1,773 |
$2K |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
198 |
192 |
$2K |
| 83540 |
|
4,251 |
4,177 |
$1K |
| 76000 |
|
561 |
552 |
$1K |
| 99152 |
|
124 |
123 |
$1K |
| 86376 |
|
1,392 |
1,377 |
$1K |
| 85652 |
|
7,962 |
7,775 |
$1K |
| 78227 |
|
28 |
24 |
$1K |
| 82670 |
|
774 |
763 |
$1K |
| 82950 |
|
3,882 |
3,859 |
$1K |
| 86039 |
|
1,442 |
1,422 |
$1K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
243 |
240 |
$1K |
| 87400 |
|
229 |
159 |
$1K |
| 86160 |
|
1,979 |
1,488 |
$1K |
| 73140 |
|
92 |
82 |
$1K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
679 |
598 |
$1K |
| 82247 |
|
269 |
243 |
$1K |
| 82570 |
|
3,956 |
3,735 |
$1K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
223 |
196 |
$1K |
| 82533 |
|
837 |
816 |
$1K |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
50 |
50 |
$1K |
| J1956 |
Injection, levofloxacin, 250 mg |
12 |
12 |
$1K |
| 92523 |
|
100 |
99 |
$1K |
| 82550 |
|
4,032 |
3,839 |
$1K |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
599 |
540 |
$1K |
| 71020 |
|
562 |
340 |
$1K |
| 84154 |
|
410 |
407 |
$997.38 |
| 97139 |
|
5,650 |
1,491 |
$994.23 |
| 72128 |
|
89 |
83 |
$956.23 |
| 29515 |
|
61 |
59 |
$931.67 |
| 78264 |
|
37 |
37 |
$930.12 |
| 88112 |
|
138 |
135 |
$920.72 |
| J0500 |
Injection, dicyclomine hcl, up to 20 mg |
53 |
53 |
$890.40 |
| 83014 |
|
1,415 |
1,411 |
$888.94 |
| 84270 |
|
731 |
708 |
$873.51 |
| 82010 |
|
2,483 |
2,293 |
$862.47 |
| 82785 |
|
556 |
531 |
$860.20 |
| 80320 |
|
637 |
581 |
$825.50 |
| J2300 |
Injection, nalbuphine hydrochloride, per 10 mg |
16 |
16 |
$818.22 |
| 86225 |
|
1,293 |
1,285 |
$802.17 |
| 70498 |
|
456 |
412 |
$790.18 |
| 84100 |
|
3,702 |
3,438 |
$778.12 |
| 94664 |
|
1,636 |
1,492 |
$726.08 |
| 84480 |
|
733 |
719 |
$718.39 |
| 85379 |
|
2,914 |
2,846 |
$718.14 |
| J1953 |
Injection, levetiracetam, 10 mg |
494 |
450 |
$707.45 |
| 82951 |
|
1,047 |
1,020 |
$705.99 |
| 84445 |
|
66 |
66 |
$699.00 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
458 |
450 |
$696.46 |
| 87338 |
|
794 |
788 |
$685.20 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
32,542 |
27,479 |
$671.43 |
| 29130 |
|
28 |
28 |
$663.84 |
| 87522 |
Neg quan hep c or qual rna |
297 |
290 |
$654.68 |
| 84144 |
|
446 |
436 |
$641.85 |
| 36600 |
|
138 |
127 |
$641.14 |
| 86171 |
|
503 |
465 |
$628.75 |
| 87205 |
|
1,565 |
1,515 |
$620.25 |
| 86800 |
|
722 |
649 |
$617.15 |
| 87220 |
|
767 |
754 |
$608.12 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
357 |
332 |
$599.35 |
| 97161 |
|
542 |
511 |
$594.25 |
| 86431 |
|
1,785 |
1,736 |
$592.96 |
| 87150 |
|
139 |
98 |
$578.61 |
| 82977 |
|
862 |
811 |
$556.21 |
| J7510 |
Prednisolone oral, per 5 mg |
331 |
327 |
$542.23 |
| 73000 |
|
32 |
24 |
$531.00 |
| 87209 |
|
156 |
146 |
$529.30 |
| 97018 |
|
2,668 |
902 |
$527.62 |
| J7999 |
Compounded drug, not otherwise classified |
15 |
15 |
$521.04 |
| 84402 |
|
278 |
269 |
$500.92 |
| 73522 |
|
152 |
138 |
$495.58 |
| 42821 |
|
15 |
12 |
$493.74 |
| 84156 |
|
2,607 |
2,265 |
$487.09 |
| 82140 |
|
1,406 |
1,319 |
$468.53 |
| 86430 |
|
762 |
753 |
$451.20 |
| 27447 |
|
12 |
12 |
$448.60 |
| 0510 |
|
503 |
397 |
$437.33 |
| 93017 |
|
48 |
48 |
$428.93 |
| 0301 |
|
856 |
799 |
$419.22 |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
111 |
106 |
$414.78 |
| 84479 |
|
1,594 |
1,588 |
$411.54 |
| 94729 |
|
133 |
133 |
$380.87 |
| 84630 |
|
858 |
846 |
$357.35 |
| J0736 |
Injection, clindamycin phosphate, 300 mg |
48 |
44 |
$354.80 |
| 71010 |
|
149 |
71 |
$323.96 |
| 86308 |
|
135 |
134 |
$318.95 |
| 82150 |
|
432 |
404 |
$316.28 |
| 0729 |
|
916 |
713 |
$316.12 |
| J1644 |
Injection, heparin sodium, per 1000 units |
254 |
162 |
$315.52 |
| 94726 |
|
104 |
104 |
$314.76 |
| 86147 |
|
97 |
80 |
$314.66 |
| J8597 |
Antiemetic drug, oral, not otherwise specified |
84 |
78 |
$313.00 |
| 82947 |
|
1,126 |
1,108 |
$312.59 |
| 32555 |
|
44 |
40 |
$308.55 |
| 97167 |
|
120 |
120 |
$304.65 |
| 82627 |
|
174 |
172 |
$299.10 |
| 88304 |
|
16 |
14 |
$294.24 |
| 86200 |
|
510 |
502 |
$278.13 |
| 74220 |
|
47 |
42 |
$276.13 |
| 83615 |
|
542 |
510 |
$268.34 |
| 77049 |
|
12 |
12 |
$264.54 |
| 86704 |
|
299 |
297 |
$253.91 |
| 82390 |
|
607 |
601 |
$252.81 |
| A9541 |
Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries |
25 |
25 |
$236.01 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
3,429 |
3,358 |
$234.34 |
| J1580 |
Injection, garamycin, gentamicin, up to 80 mg |
67 |
63 |
$232.15 |
| 84460 |
|
1,019 |
1,010 |
$214.73 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
592 |
575 |
$211.67 |
| 85576 |
|
42 |
40 |
$202.01 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
454 |
441 |
$188.24 |
| 86015 |
|
155 |
154 |
$184.48 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
13 |
13 |
$178.94 |
| 84425 |
|
266 |
264 |
$170.37 |
| J0737 |
Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg |
32 |
26 |
$157.54 |
| 87536 |
|
66 |
66 |
$151.97 |
| 82107 |
|
17 |
17 |
$140.24 |
| 83951 |
|
17 |
17 |
$140.24 |
| 83090 |
|
329 |
325 |
$136.86 |
| 0352 |
|
103 |
95 |
$132.36 |
| 74000 |
|
49 |
36 |
$131.21 |
| 96367 |
|
135 |
133 |
$125.77 |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
207 |
198 |
$123.37 |
| 83498 |
|
12 |
12 |
$119.65 |
| 97165 |
|
96 |
95 |
$119.52 |
| 84450 |
|
590 |
586 |
$113.73 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,128 |
2,916 |
$112.13 |
| 89055 |
|
158 |
157 |
$111.32 |
| 87177 |
|
156 |
147 |
$103.48 |
| 0350 |
|
26 |
25 |
$103.45 |
| A4595 |
Electrical stimulator supplies, 2 lead, per month, (e.g., tens, nmes) |
630 |
468 |
$101.61 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
18 |
12 |
$97.50 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
82 |
64 |
$95.00 |
| 87147 |
|
415 |
410 |
$92.98 |
| 97162 |
|
793 |
406 |
$92.26 |
| 86592 |
|
232 |
225 |
$87.24 |
| 82784 |
|
144 |
126 |
$85.12 |
| 84432 |
|
30 |
28 |
$84.93 |
| 81003 |
|
1,675 |
1,522 |
$81.86 |
| 87899 |
|
116 |
75 |
$78.81 |
| 74174 |
|
30 |
27 |
$73.80 |
| 86765 |
|
42 |
42 |
$72.69 |
| 99221 |
|
730 |
585 |
$71.31 |
| 82310 |
|
265 |
248 |
$67.40 |
| 72114 |
|
43 |
43 |
$64.61 |
| 72220 |
|
153 |
142 |
$63.43 |
| G0328 |
Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous |
742 |
733 |
$62.06 |
| 82952 |
|
406 |
400 |
$61.69 |
| T1015 |
Clinic visit/encounter, all-inclusive |
2,210 |
1,965 |
$60.89 |
| 0730 |
|
444 |
409 |
$59.68 |
| 94760 |
|
126 |
92 |
$57.08 |
| 86300 |
|
13 |
12 |
$56.76 |
| 92650 |
|
156 |
151 |
$56.50 |
| 87510 |
|
55 |
54 |
$54.15 |
| 87480 |
|
55 |
54 |
$54.09 |
| 72072 |
|
16 |
16 |
$48.84 |
| 0636 |
|
521 |
499 |
$48.10 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
42 |
39 |
$47.06 |
| 93880 |
|
25 |
24 |
$45.32 |
| 73070 |
|
90 |
78 |
$44.48 |
| 84132 |
|
79 |
76 |
$41.40 |
| 85613 |
|
26 |
25 |
$40.90 |
| 76881 |
|
14 |
13 |
$39.97 |
| 97116 |
|
35 |
12 |
$39.90 |
| 74330 |
|
13 |
12 |
$39.61 |
| 85045 |
|
385 |
377 |
$37.59 |
| J3360 |
Injection, diazepam, up to 5 mg |
175 |
167 |
$35.72 |
| 87046 |
|
55 |
55 |
$34.12 |
| 82652 |
|
133 |
132 |
$33.18 |
| 84590 |
|
86 |
82 |
$32.42 |
| 74240 |
|
14 |
14 |
$26.63 |
| 0761 |
|
67 |
64 |
$23.77 |
| 86364 |
|
15 |
14 |
$23.53 |
| 0305 |
|
881 |
834 |
$22.63 |
| 0306 |
|
667 |
626 |
$21.05 |
| 86334 |
|
14 |
13 |
$20.03 |
| 10005 |
|
12 |
12 |
$19.80 |
| 84165 |
|
43 |
42 |
$19.16 |
| 77001 |
|
13 |
12 |
$18.02 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
16 |
16 |
$17.24 |
| 76937 |
|
13 |
12 |
$16.73 |
| 86705 |
|
71 |
71 |
$15.56 |
| A4649 |
Surgical supply; miscellaneous |
14,373 |
11,636 |
$13.42 |
| 80177 |
|
12 |
12 |
$13.08 |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
200 |
68 |
$13.00 |
| 86695 |
|
39 |
39 |
$11.72 |
| 86708 |
|
13 |
12 |
$11.26 |
| J3105 |
Injection, terbutaline sulfate, up to 1 mg |
12 |
12 |
$10.80 |
| 84160 |
|
45 |
44 |
$10.64 |
| 0307 |
|
406 |
381 |
$10.17 |
| 85384 |
|
13 |
12 |
$10.15 |
| S0164 |
Injection, pantoprazole sodium, 40 mg |
201 |
149 |
$9.34 |
| 0302 |
|
289 |
280 |
$9.13 |
| 85018 |
|
2,140 |
2,057 |
$8.31 |
| 85014 |
|
101 |
97 |
$5.05 |
| 86849 |
|
12 |
12 |
$4.25 |
| 96376 |
|
484 |
423 |
$3.50 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
137 |
82 |
$2.15 |
| J2471 |
Injection, pantoprazole (hikma), not therapeutically equivalent to j2470, 40 mg |
22 |
16 |
$1.36 |
| 92551 |
|
671 |
670 |
$0.00 |
| 90716 |
|
98 |
98 |
$0.00 |
| 97032 |
|
828 |
538 |
$0.00 |
| 90723 |
|
87 |
84 |
$0.00 |
| A4335 |
Incontinence supply; miscellaneous |
191 |
108 |
$0.00 |
| 99000 |
|
109 |
96 |
$0.00 |
| 0420 |
|
139 |
123 |
$0.00 |
| 0258 |
|
374 |
342 |
$0.00 |
| 81000 |
|
44 |
43 |
$0.00 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
291 |
291 |
$0.00 |
| 0370 |
|
383 |
371 |
$0.00 |
| 0720 |
|
39 |
38 |
$0.00 |
| 0259R |
|
757 |
588 |
$0.00 |
| 94200 |
|
225 |
112 |
$0.00 |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
199 |
194 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
110 |
63 |
$0.00 |
| 80050 |
General health panel |
90 |
88 |
$0.00 |
| 90651 |
|
52 |
52 |
$0.00 |
| 86580 |
|
39 |
39 |
$0.00 |
| A0427 |
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) |
149 |
117 |
$0.00 |
| 94010 |
|
37 |
37 |
$0.00 |
| 93000 |
|
25 |
25 |
$0.00 |
| 98941 |
Chiropractic manipulative treatment; spinal, 3-4 regions |
794 |
522 |
$0.00 |
| K0001 |
Standard wheelchair |
38 |
38 |
$0.00 |
| T4535 |
Disposable liner/shield/guard/pad/undergarment, for incontinence, each |
418 |
214 |
$0.00 |
| 90647 |
|
80 |
80 |
$0.00 |
| 81050 |
|
12 |
12 |
$0.00 |
| G0467 |
Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
129 |
100 |
$0.00 |
| 99385 |
|
14 |
14 |
$0.00 |
| 99239 |
Hospital discharge day management, more than 30 minutes |
19 |
18 |
$0.00 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
39 |
28 |
$0.00 |
| 90674 |
|
47 |
47 |
$0.00 |
| 84446 |
|
41 |
40 |
$0.00 |
| E0562 |
Humidifier, heated, used with positive airway pressure device |
143 |
135 |
$0.00 |
| 0410 |
|
28 |
24 |
$0.00 |
| 90686 |
|
68 |
68 |
$0.00 |
| 99403 |
|
13 |
12 |
$0.00 |
| 72082 |
|
16 |
15 |
$0.00 |
| 86063 |
|
25 |
25 |
$0.00 |
| 95886 |
|
12 |
12 |
$0.00 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
83 |
59 |
$0.00 |
| A0380 |
Bls mileage (per mile) |
56 |
30 |
$0.00 |
| 90657 |
|
13 |
13 |
$0.00 |
| 36430 |
|
31 |
27 |
$0.00 |
| 90680 |
|
28 |
27 |
$0.00 |
| 80329 |
|
23 |
20 |
$0.00 |
| 95117 |
|
155 |
62 |
$0.00 |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
64 |
19 |
$0.00 |
| 99243 |
|
30 |
30 |
$0.00 |
| 87088 |
|
20 |
19 |
$0.00 |
| 74010 |
|
19 |
13 |
$0.00 |
| E0730 |
Transcutaneous electrical nerve stimulation (tens) device, four or more leads, for multiple nerve stimulation |
12 |
12 |
$0.00 |
| 19083 |
|
14 |
14 |
$0.00 |
| 90688 |
|
58 |
54 |
$0.00 |
| 87154 |
|
28 |
27 |
$0.00 |
| 73521 |
|
12 |
12 |
$0.00 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
17 |
12 |
$0.00 |
| J1920 |
Injection, labetalol hydrochloride, 5 mg |
15 |
13 |
$0.00 |
| 81002 |
|
1,269 |
1,031 |
$0.00 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,825 |
1,518 |
$0.00 |
| E0601 |
Continuous positive airway pressure (cpap) device |
232 |
219 |
$0.00 |
| 96103 |
|
39 |
39 |
$0.00 |
| 0122 |
|
26 |
25 |
$0.00 |
| 59425 |
|
445 |
325 |
$0.00 |
| 99201 |
|
722 |
491 |
$0.00 |
| 90700 |
|
38 |
38 |
$0.00 |
| A6250 |
Skin sealants, protectants, moisturizers, ointments, any type, any size |
193 |
108 |
$0.00 |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
123 |
119 |
$0.00 |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
760 |
755 |
$0.00 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
526 |
524 |
$0.00 |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
61 |
61 |
$0.00 |
| 97755 |
|
258 |
255 |
$0.00 |
| 01967 |
Neuraxial labor analgesia/anesthesia for planned vaginal delivery |
78 |
78 |
$0.00 |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
78 |
78 |
$0.00 |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
117 |
117 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
143 |
143 |
$0.00 |
| 99173 |
|
722 |
720 |
$0.00 |
| 11721 |
|
84 |
84 |
$0.00 |
| 80326 |
|
229 |
213 |
$0.00 |
| 90670 |
|
305 |
297 |
$0.00 |
| 92552 |
|
238 |
238 |
$0.00 |
| 90633 |
|
165 |
162 |
$0.00 |
| 97012 |
|
793 |
522 |
$0.00 |
| T4541 |
Incontinence product, disposable underpad, large, each |
380 |
209 |
$0.00 |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
18 |
18 |
$0.00 |
| H1002 |
Prenatal care, at risk enhanced service; care coordination |
56 |
54 |
$0.00 |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
366 |
364 |
$0.00 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
275 |
273 |
$0.00 |
| 0272 |
|
57 |
56 |
$0.00 |
| 83525 |
|
141 |
140 |
$0.00 |
| H1003 |
Prenatal care, at-risk enhanced service; education |
107 |
96 |
$0.00 |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
63 |
63 |
$0.00 |
| 99215 |
Prolong outpt/office vis |
42 |
41 |
$0.00 |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
12 |
12 |
$0.00 |
| 87660 |
|
32 |
32 |
$0.00 |
| 90707 |
|
76 |
76 |
$0.00 |
| S0028 |
Injection, famotidine, 20 mg |
130 |
127 |
$0.00 |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
118 |
118 |
$0.00 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
12 |
12 |
$0.00 |
| 82731 |
|
12 |
12 |
$0.00 |
| 80361 |
|
78 |
74 |
$0.00 |
| A7035 |
Headgear used with positive airway pressure device |
12 |
12 |
$0.00 |
| 0402 |
|
63 |
57 |
$0.00 |
| 90734 |
|
44 |
44 |
$0.00 |
| 99490 |
Ccm add 20min |
14 |
14 |
$0.00 |
| 90685 |
|
28 |
28 |
$0.00 |
| 0351 |
|
12 |
12 |
$0.00 |
| 82180 |
|
12 |
12 |
$0.00 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
113 |
54 |
$0.00 |
| 70487 |
|
30 |
25 |
$0.00 |
| 59409 |
Vaginal delivery only (with or without episiotomy and/or forceps) |
27 |
26 |
$0.00 |
| 80346 |
|
14 |
13 |
$0.00 |
| 86146 |
|
31 |
26 |
$0.00 |
| 84112 |
|
72 |
62 |
$0.00 |
| 99242 |
|
28 |
28 |
$0.00 |
| 90648 |
|
12 |
12 |
$0.00 |
| J2004 |
Injection, lidocaine hcl with epinephrine, 1 mg |
13 |
13 |
$0.00 |
| A4550 |
Surgical trays |
13 |
13 |
$0.00 |
| A0425 |
Ground mileage, per statute mile |
163 |
129 |
$0.00 |
| 76376 |
|
12 |
12 |
$0.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
13 |
13 |
$0.00 |
| E1390 |
Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate |
12 |
12 |
$0.00 |
| 90649 |
|
15 |
15 |
$0.00 |
| 82172 |
|
14 |
14 |
$0.00 |
| A0429 |
Ambulance service, basic life support, emergency transport (bls-emergency) |
23 |
21 |
$0.00 |
| A7038 |
Filter, disposable, used with positive airway pressure device |
14 |
14 |
$0.00 |
| 93041 |
|
15 |
15 |
$0.00 |
| 90658 |
|
13 |
13 |
$0.00 |